SCI Pharmtech, Inc.
Research SCI Pharmtech, Inc. (4119.TW) on Bullrun: market cap TWD 6.39B, P/E 104.9, dividend yield 1.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4119.TW
- ExchangeTW
- CountryTaiwan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyTWD
- Market capTWD 6.39B
- P/E104.9
- Dividend yield1.6%
- Financial periodQ2 2026
- RevenueTWD 272.87M
- Net income-TWD 12.85M
- Free cash flowTWD 95.76M
- Gross margin20.1%
Valuation Snapshot
latest market cap is TWD 6.39B; P/E is 104.9; dividend yield is 1.6%.
Peer valuation comparison
Latest P/E is 104.9x versus a Healthcare sector median of 21.8x (381.3% above).
Latest dividend yield is 1.55% versus a Healthcare sector median of 2.4% (35.4% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 6.39B | 104.9 | 1.4% | 0.75 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.75 TWD, yield 1.6%.
About SCI Pharmtech, Inc.
SCI Pharmtech, Inc. engages in the research and development, manufacture, and sale of active pharmaceutical ingredients, intermediates, and specialty chemicals.
ETFs that hold SCI Pharmtech, Inc.
US-listed ETFs
SCI Pharmtech, Inc. is held by 3 US-listed ETFs, going by the latest portfolios they filed with the SEC, most traded first:
| ETF | Weight | Fee |
|---|---|---|
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
| Dimensional World ex U.S. Core Equity 2 ETF (DFAX) | <0.01% | 0.28% |
| State Street SPDR S&P Emerging Markets Small Cap ETF (EWX) | 0.01% | 0.65% |
Portfolios as filed with the SEC on Form N-PORT, dated June to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is SCI Pharmtech, Inc.'s market cap?
SCI Pharmtech, Inc.'s market capitalization is TWD 6.39B.
What is SCI Pharmtech, Inc.'s P/E ratio?
SCI Pharmtech, Inc.'s price-to-earnings (P/E) ratio is 104.9.
Does SCI Pharmtech, Inc. pay a dividend?
SCI Pharmtech, Inc. has a dividend yield of 1.6%.
What does SCI Pharmtech, Inc. do?
SCI Pharmtech, Inc. engages in the research and development, manufacture, and sale of active pharmaceutical ingredients, intermediates, and specialty chemicals.